Blood thinner switch may skew lab results, study warns

NCT ID NCT07302620

Recruiting now Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at whether common blood thinners like heparin can mess up lab tests for another blood thinner, argatroban. Doctors often switch patients from heparin to argatroban, but current tests can't tell the two drugs apart. Researchers will analyze blood samples from 70 adults on heparin to see if leftover heparin causes false high readings of argatroban, which could lead to dangerous dosing mistakes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors more accurately monitor argatroban levels in patients switching from heparin, reducing bleeding or clotting risks.
What could go wrong: This is a small, observational study (70 participants) that only looks at lab test accuracy, not patient outcomes. It may not change clinical practice directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOEMBOLIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Thromboembolism thrombotic disease venous thromboembolism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

THROMBOEMBOLIC DISEASE

Contacts and locations

Locations

Laboratoire d'Hématologie - Unité d'Hémostase - CHU de Strasbourg - France
RECRUITING

Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.